Abstract
One of the key potential benefits of NAC is to sterilise the axilla of patients who present with axillary stage positive disease. In certain patients, this allows axillary conservation as opposed to an axillary clearance (ANC). This unit’s standard practice was to offer TAD to patients with node positive disease with favourable biology following NAC if a radiological response had been seen. This prospective study considers the impact of this approach to the management of these patients in a real-world setting.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
